TrialInternational journal of hematology2021

Minimal residual disease (MRD) positivity at allogeneic hematopoietic cell transplantation, not the quantity of MRD, is a risk factor for relapse of Philadelphia chromosome-positive acute lymphoblastic leukemia.

Yu Akahoshi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.